Overview
- 6 inspections across 6 sites are on record.
- 28 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-03-18.
At a glance
Inspections
6
Sites
6
Observations
28
Career since
Dec 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Arnold Professional Pharmacy | 18 Mar 2022 | Human Drugs | View 483 → |
| Granules Pharmaceuticals Inc. | 28 Jan 2022 | Human Drugs | View 483 → |
| Aphena Pharma Solutions - Maryland, LLC | 15 Dec 2021 | Human Drugs | View 483 → |
| SpecGx LLC | 13 Mar 2020 | Human Drugs | |
| Jubilant Cadista Pharmaceuticals, Inc. | 28 Feb 2020 | Human Drugs | View 483 → |
Sites inspected
Arnold Professional PharmacyArnold, United States1 insp.
Granules Pharmaceuticals Inc.Chantilly, United States1 insp.
Aphena Pharma Solutions - Maryland, LLCEaston, United States1 insp.
SpecGx LLCHobart, United States1 insp.
Jubilant Cadista Pharmaceuticals, Inc.Salisbury, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Marcia D Fields2 shared
Natasha Gupta1 shared
Sena G Dissmeyer1 shared
William J Leonard1 shared
Juliana M Badalucco1 shared
Mindy M Chou1 shared
Marcus A Ray1 shared
Sony Mathews1 shared
Marcellinus D Dordunoo1 shared
Full investigator report
Get the verbatim findings behind Roseline N Boateng's 28 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site